The vaccine development has been well anticipated by everyone around the world. But the question remains on how the vaccine shall be fairly accessed by different countries (through COVAX), and how effective will it be.

NordCham Philippines in partnership with the German-Philippine Chamber of Commerce and Industry and event partner BASF, would like to invite you to this webinar and hear the latest progress and reflect on these crucial questions.

About the Speaker

Edsel Salvana, MD, DTM&H, FPCP, FIDSA

Director, Institute of Molecular Biology,

NIH, University of the Philippines

Technical Advisor, Technical Advisory Group,

DOH for IATF

Dr. Salvana is the Director of the Institute of Molecular Biology and Biotechnology at the National Institutes of Health at the University of the Philippines Manila, and is Clinical Associate Professor and Research Coordinator at the Section of Infectious Diseases of the Department of Medicine at the Philippine General Hospital. He is also Adjunct Professor for Global Health at the University of Pittsburgh.

He is currently the head of the subcommittee for HIV of the Philippine Society for Microbiology and Infectious Diseases and led the formulation of local clinical practice guidelines for the treatment of opportunistic infections in HIV. He also sits as an institutional representative on the Global Fund Country Coordinating Mechanism. Currently he is also a member of DOH Technical Advisory Group that advises the IATF in fight against COVID-19.

This event is free for NordCham business partners and friends to attend.